Quest Diagnostics (DGX) Revenue — Quarter Ended Mar 31, 2025
Revenue for the reported quarter rose compared to the prior quarter. It also increased relative to the same quarter a year earlier.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the reported quarter rose compared to the prior quarter. It also increased relative to the same quarter a year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.7B
Revenue reported for this quarter.
Quarter-over-quarter
+1.2%
Change from the immediately preceding quarter.
Year-over-year
+12.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$10.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $2.4B | +2.5% |
| Sep 30, 2024 | $2.5B | +8.4% |
| Dec 31, 2024 | $2.6B | +14.6% |
| Mar 31, 2025 | $2.7B | +12.1% |
Revenue performance
The reported revenue increased during the quarter.
Quarterly comparison
The sequential increase was smaller than the advance from the prior year's same quarter.
What to watch
The company's filing indicates no material changes in risk factors and mentions ongoing legal proceedings.